| Issue |
Section |
Title |
File |
| Vol 160, No 5 (2016) |
Article |
Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro Modeled Glutamate Neurotoxicity |
|
| Vol 161, No 1 (2016) |
Article |
Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model |
|
| Vol 161, No 4 (2016) |
Article |
Pharmacological Correction of Alcohol Motivation Depends on the Phenotype of the Response to Emotional Stress |
|
| Vol 161, No 4 (2016) |
Article |
Angiogenic Effects of Dimeric Dipeptide Mimetic of Loop 4 of Nerve Growth Factor |
|
| Vol 162, No 4 (2017) |
Article |
Dipeptide Mimetic of the Brain-derived Neurotrophic Factor Prevents Impairments of Neurogenesis in Stressed Mice |
|
| Vol 163, No 1 (2017) |
Pharmacology and Toxicology |
Antiangiogenic Effects of Nerve Growth Factor Loop 4 Monomeric Dipeptide Mimetic |
|
| Vol 164, No 2 (2017) |
Article |
Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats |
|
| Vol 164, No 6 (2018) |
Pharmacology and Toxicology |
Antidiabetic Properties of Low-Molecular-Weight BDNF Mimetics Depend on the Type of Activation of Post-Receptor Signaling Pathways |
|
| Vol 166, No 4 (2019) |
Article |
Drug with Neuroprotective Properties Noopept Does Not Stimulate Cell Proliferation |
|
| Vol 167, No 1 (2019) |
Pharmacology and Toxicology |
Effect of Endogenous Neuropeptide Cycloprolylglycine on GABAA Receptors in Cerebellar Purkinje Cells |
|
| Vol 167, No 4 (2019) |
Article |
Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction |
|
| Vol 168, No 2 (2019) |
Pharmacology and Toxicology |
Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes |
|
